Endothelial cell-to-cell junctions: Adhesion and signaling in physiology and pathology

Cold Spring Harbor Perspectives in Medicine

Volumn 2, Issue 10, 2012, Pages

  Lampugnani, Maria Grazia ^a,b  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CD31 ANTIGEN; CLAUDIN 5; EPITHELIAL CELL ADHESION MOLECULE; GROWTH FACTOR RECEPTOR; JUNCTIONAL ADHESION MOLECULE A; JUNCTIONAL ADHESION MOLECULE C; PROTEIN P120; PROTEIN ZO1; RAP1 PROTEIN; TRANSCRIPTION FACTOR FKHR; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A;

ANGIOGENESIS; ARTICLE; CAVERNOUS HEMANGIOMA; CELL ADHESION; CELL FUNCTION; CELL JUNCTION; DNA MODIFICATION; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; INTRACELLULAR SIGNALING; MORPHOGENESIS; NONHUMAN; PHENOTYPE; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; ANIMAL; CONGENITAL BLOOD VESSEL MALFORMATION; GENETICS; NEOPLASM; PATHOLOGY; REVIEW; TIGHT JUNCTION; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

ADHERENS JUNCTIONS; ANIMALS; CELL ADHESION; ENDOTHELIUM, VASCULAR; HUMANS; INTERCELLULAR JUNCTIONS; NEOPLASMS; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; VASCULAR MALFORMATIONS;

EID: 84876439445     PISSN: None     EISSN: 21571422     Source Type: Journal    
DOI: 10.1101/cshperspect.a006528     Document Type: Article

References (86)

1. Ayalon O, Sabanai H, Lampugnani MG, Dejana E, Geiger B. 1994. Spatial and temporal relationships between cadherins and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol 126: 247-258.
2. Baluk P, Hashizume H, McDonald DM. 2005. Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15: 102-111.
3. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, Vestweber D, Corada C, Molendini C, Dejana E, et al. 2007. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 204: 2349-2362.
4. Baluk P, Yao LC, Feng J, Romano T, Jung SS, Schreiter JL, Yan L, Shealy DJ, McDonald DM. 2009. TNF-α drives remodeling of blood vessels and lymphatics in sustained airway inflammation in mice. J Clin Invest 119: 2954-2964.
5. Baumer S, Keller L, Holtmann A, Funke R, August B, Gamp A, Wolburg H, Wolburg-Buchholz K, Deutsch U, Vestweber D. 2006. Vascular endothelial cell-specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development. Blood 107: 4754-4762.
6. Boulday G, Blecon A, Petit N, Chareyre F, Garcia LA, Niwa-Kawakita M, Giovannini M, Tournier-Lasserve E. 2009. Tissue-specific conditional CCM2 knockout mice establish the essential role of endothelial CCM2 in angiogenesis: Implications for human cerebral cavernous malformations. Dis Model Mech 2: 168-177.
7. Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, Balconi G, Spagnuolo R, Oosthuyse B, Dewerchin M, et al. 1999. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 98: 147-157.
8. Carrithers M, Tandon S, Canosa S, Michaud M, Graesser D, Madri JA. 2005. Enhanced susceptibility to endotoxic shock and impaired STAT3 signaling in CD31-deficient mice. Am J Pathol 166: 185-196.
9. Cattelino A, Liebner S, Gallini R, Zanetti A, Balconi G, Corsi A, Bianco P, Wolburg H, Moore R, Oreda B, et al. 2003. The conditional inactivation of the β-catenin gene in endothelial cells causes a defective vascular pattern and increased vascular fragility. J Cell Biol 162: 1111-1122.
10. Cera MR, Del Prete, Vecchi A, Corada M, Motoike T, Tonetti P, Bazzoni G, VermiW, Gentili F, Bernasconi S, et al. 2004. Increased DC trafficking to lymph nodes and contact hypersensitivity in junctional adhesion molecule-A-deficient mice. J Clin Invest 114: 729-738.
11. Chrzanowska-Wodnicka M, Kraus AE, Gale D, White GC 2nd., Vansluys J. 2008. Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood 111: 2647-2656.
12. Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D. 2001. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 71: 188-192.
13. Cooke VG, Naik MU, Naik UP. 2006. Fibroblast growth factor-2 failed to induce angiogenesis in junctional adhesion molecule-A-deficient mice. Arterioscler Thromb Vasc Biol 26: 2005-2011.
14. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, Lampugnani MG, Stoppacciaro A, Ruco L, McDonald DM, et al. 1999. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci 96: 9815-9820.
15. Corada M, Nyqvist D, Orsenigo F, Caprini A, Giampietro C, Taketo MM, Iruela-Arispe ML, Adams RH, Dejana E. 2010. The Wnt/β-catenin pathway modulates vascular remodeling and specification by upregulating Dll4/Notch signaling. Dev Cell 18: 938-949.
16. Daniel JM. 2007. Dancing in and out of the nucleus: p120(ctn) and the transcription factor Kaiso. Biochim Biophys Acta 1773: 59-68.
17. De Val S, Black BL. 2009. Transcriptional control of endothelial cell development. Dev Cell 16: 180-195.
18. Dejana E, Tournier-Lasserve E, Weinstein BM. 2009. The control of vascular integrity by endothelial cell junctions: Molecular basis and pathological implications. Dev Cell 16: 209-221.
19. Dejana E. 2010. The role of Wnt signaling in physiological and pathological angiogenesis. Circ Res 107: 943-952.
20. Dominguez MG, Hughes VC, Pan L, Simmons M, Daly C, Anderson K, MurphyAJ, Valenzuela DM, Davis S, Thurston G, et al. 2007. Vascular endothelial tyrosine phosphatase (VE-PTP)-null mice undergo vasculogenesis but die embryonically because of defects in angiogenesis. Proc Natl Acad Sci 104: 3243-3248.
21. Duan LJ, Imamoto A, Fong GH. 2004. Dual roles of the C-terminal Src kinase (Csk) during developmental vascularization. Blood 103: 1370-1372.
22. Engelhardt B. 2003. Development of the blood-brain barrier. Cell Tissue Res 314: 119-129.
23. Fachinger G, Deutsch U, Risau W. 1999. Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 18: 5948-5953.
24. Fukumura D, Jain RK. 2007. Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization. Microvasc Res 74: 72-84.
25. Fukumura D, Duda DG, Munn LL, Jain RK. 2010. Tumor microvasculature and microenvironment: Novel insights through intravital imaging in pre-clinical models. Microcirculation 17: 206-225.
26. Gaengel K, Genove G, Armulik A, Betsholtz C. 2009. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol 29: 630-638.
27. Gallicano GI, Bauer C, Fuchs E. 2001. Rescuing desmoplakin function in extra-embryonic ectoderm reveals the importance of this protein in embryonic heart, neuroepithelium, skin and vasculature. Development 128: 929-941.
28. Glading A, Han J, Stockton RA, Ginsberg MH. 2007. KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol 179: 247-254.
29. Gore AV, Lampugnani MG, Dye L, Dejana E, Weinstein BM. 2008. Combinatorial interaction between CCM pathway genes precipitates hemorrhagic stroke. Dis Model Mech 1: 275-281.
30. He Y, Zhang H, Yu L, Gunel M, Boggon TJ, Chen H, Min W. 2010. Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development. Sci Signal 3: ra26.
31. Hogan BM, Bussmann J, Wolburg H, Schulte-Merker S. 2008. ccm1 cell autonomously regulates endothelial cellular morphogenesis and vascular tubulogenesis in zebrafish. Hum Mol Genet 17: 2424-2432.
32. Ishida T, Kundu RK, Yang E, Hirata K, Quertermous T. 2003. Targeted disruption of endothelial cell-selective adhesion molecule inhibits angiogenic processes in vitro and in vivo. J Biol Chem 278: 34598-34604.
33. Isogai S, Hitomi J, Yaniv K, Weinstein BM. 2009. Zebrafish as a new animal model to study lymphangiogenesis. Anat Sci Int 84: 102-111.
34. Jain RK. 2005. Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy. Science 307: 58-62.
35. Jin SW, Beis D, Mitchell T, Chen JN, Stainier DY. 2005. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development 132: 5199-5209.
36. Katsuno T, Umeda K, Matsui T, Hata M, Tamura A, Itoh M, Takeuchi K, FujimoriT, Nabeshima Y, Noda T, et al. 2008. Deficiency of zonula occludens-1 causes embryonic lethal phenotype associated with defected yolk sac angiogenesis and apoptosis of embryonic cells. Mol Biol Cell 19: 2465-2475.
37. Kawata M, Matsui Y, Kondo J, Hishida T, Teranishi Y, Takai Y. 1988. A novel small molecular weight GTP-binding protein with the same putative effector domain as the ras proteins in bovine brain membranes. Purification, determination of primary structure, and characterization. J Biol Chem 263: 18965-18971.
38. Kleaveland B, Zheng X, Liu JJ, Blum Y, Tung JJ, Zou Z, Sweeney SM, Chen M, Guo L, Lu MM, et al. 2009. Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat Med 15: 169-176.
39. Kniesel U, Risau W, Wolburg H. 1996. Development of blood-brain barrier tight junctions in the rat cortex. Brain ResDevBrain Res 96: 229-240.
40. Kooistra MR, Corada M, Dejana E, Bos JL. 2005. Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett 579: 4966-4972.
41. Labauge P, Denier C, Bergametti F, Tournier-Lasserve E. 2007. Genetics of cavernous angiomas. Lancet Neurol 6: 237-244.
42. Lampugnani MG. 2010. Endothelial adherens junctions and the actin cytoskeleton: An "infinity net"? J Biol 9: 16.
43. Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G, Ruco LP, Dejana E. 1992. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 118: 1511-1522.
44. Lampugnani M, Zanetti A, Corada M, Takahashi T, Balconi G, Breviario F, Orsenigo F, Cattelino A, Kemler R, Daniel TO, et al. 2003. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, β-catenin, and the phosphatase DEP-1/CD148. J Cell Biol 161: 793-804.
45. Lampugnani MG, Orsenigo F, Gagliani MC, Tacchetti C, Dejana E. 2006. Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments. J Cell Biol 174: 593-604.
46. Lampugnani MG, Orsenigo F, Rudini N, Maddaluno L, Boulday G, Chapon F, Dejana E. 2010. CCM1 regulates vascular-lumen organization by inducing endothelial polarity. J Cell Sci 123: 1073-1080.
47. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, Ferrara N, Nagy A, Roos KP, Iruela-Arispe ML. 2007. Autocrine VEGF signaling is required for vascular homeostasis. Cell 130: 691-703.
48. Liao F, Doody JF, Overholser J, Finnerty B, Bassi R, Wu Y, Dejana E, Kussie P, Bohlen P, Hicklin DJ. 2002. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Cancer Res 62: 2567-2575.
49. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, et al. 2008. Wnt/β-catenin signaling controls development of the blood-brain barrier. J Cell Biol 183: 409-417.
50. Loges S, Mazzone M, Hohensinner P, Carmeliet P. 2009. Silencing or fueling metastasis with VEGF inhibitors: Antiangiogenesis revisited. Cancer Cell 15: 167-170.
51. Luo Y, Radice GL. 2005. N-cadherin acts upstream of VE-cadherin in controlling vascular morphogenesis. J Cell Biol 169: 29-34.
52. Mably JD, Mohideen MA, Burns CG, Chen JN, Fishman MC. 2003. Heart of glass regulates the concentric growth of the heart in zebrafish. Curr Biol 13: 2138-2147.
53. Mably JD, Chuang LP, Serluca FC, Mohideen MPK, Chen JN, Fishman MC. 2006. Santa and valentine pattern concentric growth of cardiac myocardium in the zebrafish. Development 133: 3139-3146.
54. Maher MT, Flozak AS, Stocker AM, Chenn A, Gottardi CJ. 2009. Activity of the β-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J Cell Biol 186: 219-228.
55. Martin-Belmonte F, Mostov K. 2008. Regulation of cell polarity during epithelial morphogenesis. Curr Opin Cell Biol 20: 227-234.
56. May C, Doody JF, Abdullah R, Balderes P, Xu X, Chen CP, Zhu Z, Shapiro L, Kussie P, Hicklin DJ, et al. 2005. Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. Blood 105: 4337-4344.
57. Mazzone M, Dettori D, Leite de Oliveira, Loges S, Schmidt T, Jonckx B, TianYM, Lanahan AA, Pollard P, Ruiz de Almodovar, et al. 2009. Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136: 839-851.
58. Millan J, Cain RJ, Reglero-Real N, Bigarella C, Marcos-Ramiro B, Fernandez-Martin L, Correas I, Ridley AJ. 2010. Adherens junctions connect stress fibres between adjacent endothelial cells. BMC Biol 8: 11.
59. Montero-Balaguer M, Swirsding K, Orsenigo F, Cotelli F, Mione M, Dejana E. 2009. Stable vascular connections and remodeling require full expression of VE-cadherin in zebrafish embryos. PLoS One 4: e5772.
60. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S. 2003. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol 161: 653-660.
61. Nottebaum AF, Cagna G, Winderlich M, Gamp AC, Linnepe R, Polaschegg C, Filippova K, Lyck R, Engelhardt B, Kamenyeva O, et al. 2008. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF. J Exp Med 205: 2929-2945.
62. Nyqvist D, Giampietro C, Dejana E. 2008. Deciphering the functional role of endothelial junctions by using in vivo models. EMBO Rep 9: 742-747.
63. Oas RG, Xiao K, Summers S, Wittich KB, Chiasson CM, Martin WD, GrossniklausHE, Vincent PA, Reynolds AB, Kowalczyk AP. 2010. 120-Catenin is required for mouse vascular development. Circ Res 106: 941-951.
64. Orlova VV, Economopoulou M, Lupu F, Santoso S, Chavakis T. 2006. Junctional adhesion molecule-C regulates vascular endothelial permeability by modulating VE-cadherin-mediated cell-cell contacts. J Exp Med 203: 2703-2714.
65. Pannekoek WJ, Kooistra MR, Zwartkruis FJ, Bos JL. 2009. Cell-cell junction formation: The role of Rap1 and Rap1 guanine nucleotide exchange factors. Biochim Biophys Acta 1788: 790-796.
66. Pitulescu ME, Schmidt I, Benedito R, Adams RH. 2010. Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice. Nat Protoc 5: 1518-1534.
67. Qin Y, Capaldo C, Gumbiner BM, Macara IG. 2005. The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol 171: 1061-1071.
68. Rudini N, Felici A, Giampietro C, Lampugnani M, Corada M, Swirsding K, GarreM, Liebner S, Letarte M, ten Dijke, et al. 2008. VE-cadherin is a critical endothelial regulator of TGF-β signalling. Embo J 27: 993-1004.
69. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, et al. 2008. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Nat Cell Biol 10: 527-537.
70. Saharinen P, Bry M, Alitalo K. 2010. How do angiopoietins Tie in with vascular endothelial growth factors? Curr Opin Hematol 17: 198-205.
71. Shimizu M, Fukunaga Y, Ikenouchi J, Nagafuchi A. 2008. Defining the roles of β-catenin and plakoglobin in LEF/T-cell factor-dependent transcription using β-catenin/plakoglobin-null F9 cells. Mol Cell Biol 28: 825-835.
72. Simionescu M, Simionescu N, Palade GE. 1975. Segmental differentiations of cell junctions in the vascular endothelium. The microvasculature. J Cell Biol 67: 863-885.
73. Stenman JM, Rajagopal J, Carroll TJ, Ishibashi M, McMahon J, McMahon AP. 2008. Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science 322: 1247-1250.
74. Stockton RA, Shenkar R, Awad IA, Ginsberg MH. 2010. Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med 207: 881-896.
75. Swift MR, Weinstein BM. 2009. Arterial-venous specification during development. Circ Res 104: 576-588.
76. Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V, PotenteM, Daly C, Dimmeler S, Dejana E. 2008. Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10: 923-934.
77. Takahashi T, Takahashi K, St John PL, Fleming PA, Tomemori T, Watanabe T, Abrahamson DR, Drake CJ, Shirasawa T, Daniel TO. 2003. A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol Cell Biol 23: 1817-1831.
78. Tawa H, Rikitake Y, Takahashi M, Amano H, Miyata M, Kinugasa M, NagamatsuY, Majima T, Ogita H, Miyoshi J, et al. 2010. Role of afadin in vascular endothelial growth factor-and sphingosine 1-phosphate-induced angiogenesis. Circ Res 106: 1731-1742.
79. Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, CaoG, DeLisser H, Schwartz MA. 2005. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437: 426-431.
80. Voss K, Stahl S, Hogan BM, Reinders J, Schleider E, Schulte-Merker S, Felbor U. 2009. Functional analyses of human and zebrafish 18-amino acid in-frame deletion pave the way for domain mapping of the cerebral cavernous malformation 3 protein. Hum Mutat 30: 1003-1011.
81. Wegmann F, Petri B, Khandoga AG, Moser C, Khandoga A, Volkery S, Li H, Nasdala I, Brandau O, Fassler R, et al. 2006. ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med 203: 1671-1677.
82. Whitehead KJ, Plummer NW, Adams JA, Marchuk DA, Li DY. 2004. Ccm1 is required for arterial morphogenesis: implications for the etiology of human cavernous malformations. Development 131: 1437-1448.
83. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, MayoAH, Drakos SG, Jones CA, Zhu W, et al. 2009. The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med 15: 177-184.
84. Winderlich M, Keller L, Cagna G, Broermann A, Kamenyeva O, Kiefer F, Deutsch U, Nottebaum AF, Vestweber D. 2009. VE-PTP controls blood vessel development by balancing Tie-2 activity. J Cell Biol 185: 657-671.
85. Wolburg H, Wolburg-Buchholz K, Kraus J, Rascher-Eggstein G, Liebner S, Hamm S, Duffner F, Grote EH, Risau W, Engelhardt B. 2003. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol 105: 586-592.
86. Zheng X, Xu C, Di Lorenzo, Kleaveland B, Zou Z, Seiler C, Chen M, Cheng L, Xiao J, He J, et al. 2010. CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. J Clin Invest 120: 2795-2804.